tiprankstipranks
OncoArendi Therapeutics SA (PL:MOC)
:MOC
Poland Market

OncoArendi Therapeutics SA (MOC) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Buy
13Bullish
4Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
OncoArendi Therapeutics SA’s (MOC) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting OncoArendi Therapeutics SA is a Sell.
OncoArendi Therapeutics SA’s (MOC) 20-Day exponential moving average is 5.65, while OncoArendi Therapeutics SA’s (MOC) share price is zł5.2, making it a Buy.
OncoArendi Therapeutics SA’s (MOC) 50-Day exponential moving average is 5.68, while OncoArendi Therapeutics SA’s (MOC) share price is zł5.2, making it a Buy.

OncoArendi Therapeutics SA (MOC) Pivot Points

Jul 06, 2026, 04:38 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.03
5.21
5.52
5.70
6.01
6.19
6.50
Fibonacci
5.21
5.40
5.52
5.70
5.89
6.01
6.19
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

OncoArendi Therapeutics SA (MOC) Moving Averages

Jul 06, 2026, 04:38 PM
Period
Simple
Exponential
MA5
5.66Buy
5.75Buy
MA10
5.60Buy
5.67Buy
MA20
5.65Buy
5.65Buy
MA50
5.61Buy
5.68Buy
MA100
5.92Buy
5.91Buy
MA200
6.46Sell
6.34Sell
OncoArendi Therapeutics SA’s (MOC) 10-Day exponential moving average is 5.67, while OncoArendi Therapeutics SA’s (MOC) share price is zł5.2, making it a Buy.
OncoArendi Therapeutics SA’s (MOC) 100-Day exponential moving average is 5.91, while OncoArendi Therapeutics SA’s (MOC) share price is zł5.2, making it a Buy.
OncoArendi Therapeutics SA’s (MOC) stock price is zł5.2 and OncoArendi Therapeutics SA’s (MOC) 50-day simple moving average is 5.61, creating a Buy signal.
OncoArendi Therapeutics SA’s (MOC) stock price is zł5.2 and OncoArendi Therapeutics SA’s (MOC) 100-day simple moving average is 5.92, creating a Buy signal.
OncoArendi Therapeutics SA’s (MOC) stock price is zł5.2 and OncoArendi Therapeutics SA’s (MOC) 200-day simple moving average is 6.46, creating a Sell signal.

OncoArendi Therapeutics SA (MOC) Technical Indicators

Jul 06, 2026, 04:38 PM
Name
Value
Implied Action
RSI (14)
62.63
Neutral
STOCH (9,6)
68.23
Neutral
STOCHRSI (14)
72.34
Neutral
MACD (12,26)
0.02
Sell
ADX (14)
17.88
Buy
Williams %R
-8.11
Sell
CCI (14)
141.51
Sell
ATR (14)
0.31
-
Ultimate Oscillator
60.49
Neutral
ROC
6.34
Buy
OncoArendi Therapeutics SA’s (MOC) Relative Strength Index (RSI) is 62.63, creating a Neutral signal.
OncoArendi Therapeutics SA’s (MOC) Trend Strength Indicator (ADX) is 17.88, creating a Buy signal.
OncoArendi Therapeutics SA’s (MOC) Commodity Channel Index (CCI) is 141.51, creating a Sell signal.
OncoArendi Therapeutics SA’s (MOC) Price Rate of Change (ROC) is 6.34, creating a Buy signal.

FAQ

Is MOC a Buy, Hold, or Sell?
Based on MOC’s technical indicators, MOC is a Buy.
    What is MOC’s RSI (14)?
    MOC’s RSI (14) is 62.63, which suggests MOC is a Neutral.
      What is MOC’s MACD?
      MOC’s MACD is 0.02, which suggests MOC is a Sell.
        What is MOC’s 5-day moving average?
        MOC’s 5-day moving average is 5.66, which suggests MOC is a Buy.
          What is MOC’s 20-day moving average?
          MOC 20-day moving average is 5.65, which suggests MOC is a Buy.
            What is MOC’s 50-day moving average?
            MOC’s 50-day moving average is 5.61, which suggests MOC is a Buy.
              What is MOC’s 200-day moving average?
              MOC’s 200-day moving average is 6.46, which suggests MOC is a Sell.
                What is MOC’s Williams % R (14)?
                MOC’s Williams % R (14) is -8.11, which suggests MOC is a Sell.
                  What is MOC’s CCI (14)?
                  MOC’s CCI (14) is 141.51, which suggests MOC is a Sell.
                    What is the share price of OncoArendi Therapeutics SA?